Unique ID issued by UMIN | UMIN000041508 |
---|---|
Receipt number | R000047357 |
Scientific Title | Database study of adverse events in atezolizumab combination with carboplatin plus etoposide in patients with previously untreated extensive disease small cell lung cancer |
Date of disclosure of the study information | 2020/08/21 |
Last modified on | 2020/08/21 18:51:07 |
Database study of adverse events in atezolizumab combination with carboplatin plus etoposide in patients with previously untreated extensive disease small cell lung cancer
Database study of adverse events in atezolizumab combination with carboplatin plus etoposide in patients with previously untreated extensive disease small cell lung cancer
Database study of adverse events in atezolizumab combination with carboplatin plus etoposide in patients with previously untreated extensive disease small cell lung cancer
Database study of adverse events in atezolizumab combination with carboplatin plus etoposide in patients with previously untreated extensive disease small cell lung cancer
Japan |
Small cell lung cancer
Pneumology | Hematology and clinical oncology |
Malignancy
NO
To investigate the safety of atezolizumab combination with carboplatin plus etoposide using a database from DPC in patients with previously untreated extensive disease small cell lung cancer in Japan
Safety
Incidence, rates, severity and time to onset of adverse events, and treatment for adverse events
Observational
Not applicable |
Not applicable |
Male and Female
Patients with small cell lung cancer
Patients who have been diagnosed with malignant tumors other than small cell lung cancer and have undergone chemotherapy for small cell lung cancer
400
1st name | Kaori |
Middle name | |
Last name | Ouchi |
CHUGAI PHARMACEUTICAL CO., LTD.
Medical Affairs Div.
103-8324
1-1 Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo 103-8324, Japan
0332730866
cma-clinicaltrial@chugai-pharm.co.jp
1st name | CHUGAI PHARMACEUTICAL |
Middle name | |
Last name | CO., LTD. |
Medical Affairs Div.
Medical Science Dept.
103-8324
1-1 Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo 103-8324, Japan
0332730866
cma-clinicaltrial@chugai-pharm.co.jp
CHUGAI PHARMACEUTICAL CO., LTD.
CHUGAI PHARMACEUTICAL CO., LTD.
Profit organization
Japan
Non-Profit Organization MINS Institutional Review Board
1-15-14, Dogenzaka, Shibuya, Tokyo, Japan
0364161868
npo-mins@j-irb.com
NO
2020 | Year | 08 | Month | 21 | Day |
Unpublished
Preinitiation
2020 | Year | 06 | Month | 18 | Day |
2020 | Year | 06 | Month | 18 | Day |
2020 | Year | 08 | Month | 24 | Day |
2020 | Year | 12 | Month | 31 | Day |
A cohort study using a Japanese healthcare database
2020 | Year | 08 | Month | 21 | Day |
2020 | Year | 08 | Month | 21 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047357
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |